Identifying Influencing Factors and Constructing a Prediction Model for Long COVID-19 in Hemodialysis Patients

Overview

Journal Int Urol Nephrol

Publisher Springer

Specialty Nephrology

Date 2024 Nov 11

PMID 39527314

Authors

Ding Chen

Xinlun Li

Chang Xiao

Wangyan Xiao

Linjing Lou

Zhuo Gao

Affiliations

Soon will be listed here.

Abstract

Purpose: This study aimed to identify the potential influencing factors and construct a prediction model for long COVID in hemodialysis patients.

Methods: We retrospectively reviewed 115 patients undergoing hemodialysis in a tertiary hospital between December 2022 and January 2023. Both univariate and multivariate logistic regression models were applied to identify potential influencing factors, and the prediction model was constructed using an ROC curve.

Results: Of the 115 included patients, 60 experienced long COVID, with a prevalence of 52.2%. The univariate analysis found that a three-dose COVID-19 vaccination was associated with a reduced risk of long COVID (OR: 0.10; 95%CI: 0.01-0.86; P = 0.036). However, severe COVID (OR: 9.49; 95%CI: 1.14-78.90; P = 0.037), undergoing CT examination (OR: 3.01; 95%CI: 1.34-6.78; P = 0.008), and abnormal neutrophil (OR: 5.95; 95%CI: 1.26-28.19; P = 0.025), and platelet (OR: 2.39; 95%CI: 1.11-5.13; P = 0.025) counts were associated with a higher risk of long COVID. After adjusting for potential confounding factors, undergoing CT examination (OR: 2.60; 95%CI: 1.02-6.64; P = 0.046) and having abnormal neutrophil (OR: 8.16; 95%CI: 1.57-42.38; P = 0.013) and monocyte (OR: 17.77; 95%CI: 1.30-242.29; P = 0.031) counts were associated with a higher risk of long COVID. The prediction model constructed based on these factors showed a relatively better predictive value (AUC: 0.738; 95%CI: 0.648-0.828; P < 0.001).

Conclusions: The risk of long COVID-19 in hemodialysis patients was significantly related to undergoing CT examination and having abnormal neutrophil and monocyte counts, and the prediction model constructed using these factors showed a moderate predictive value.

References

Bassler K, Schulte-Schrepping J, Warnat-Herresthal S, Aschenbrenner A, Schultze J . The Myeloid Cell Compartment-Cell by Cell. Annu Rev Immunol. 2019; 37:269-293. DOI: 10.1146/annurev-immunol-042718-041728. View

Mann E, Menon M, Knight S, Konkel J, Jagger C, Shaw T . Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19. Sci Immunol. 2020; 5(51). PMC: 7857390. DOI: 10.1126/sciimmunol.abd6197. View

Soriano J, Murthy S, Marshall J, Relan P, Diaz J . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2021; 22(4):e102-e107. PMC: 8691845. DOI: 10.1016/S1473-3099(21)00703-9. View

Kreuter M, Lee J, Tzouvelekis A, Oldham J, Molyneaux P, Weycker D . Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2021; 204(1):74-81. PMC: 8437112. DOI: 10.1164/rccm.202003-0669OC. View

Altmann D, Whettlock E, Liu S, Arachchillage D, Boyton R . The immunology of long COVID. Nat Rev Immunol. 2023; 23(10):618-634. DOI: 10.1038/s41577-023-00904-7. View

Chancharoenthana W, Kamolratanakul S, Leelahavanichkul A, Ariyanon W, Chinpraditsuk S, Saelim R . Gastrointestinal manifestations of long-term effects after COVID-19 infection in patients with dialysis or kidney transplantation: An observational cohort study. World J Gastroenterol. 2023; 29(19):3013-3026. PMC: 10237091. DOI: 10.3748/wjg.v29.i19.3013. View

Nehme M, Vetter P, Chappuis F, Kaiser L, Guessous I . Prevalence of Post-Coronavirus Disease Condition 12 Weeks After Omicron Infection Compared With Negative Controls and Association With Vaccination Status. Clin Infect Dis. 2022; 76(9):1567-1575. DOI: 10.1093/cid/ciac947. View

Gansevoort R, Hilbrands L . CKD is a key risk factor for COVID-19 mortality. Nat Rev Nephrol. 2020; 16(12):705-706. PMC: 7447963. DOI: 10.1038/s41581-020-00349-4. View

Kahlert C, Strahm C, Gusewell S, Cusini A, Brucher A, Goppel S . Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study. Clin Infect Dis. 2023; 77(2):194-202. PMC: 10371307. DOI: 10.1093/cid/ciad143. View

10.

Och A, Tylicki P, Polewska K, Puchalska-Reglinska E, Parczewska A, Szabat K . Persistent Post-COVID-19 Syndrome in Hemodialyzed Patients-A Longitudinal Cohort Study from the North of Poland. J Clin Med. 2021; 10(19). PMC: 8509624. DOI: 10.3390/jcm10194451. View

11.

Liao M, Liu Y, Yuan J, Wen Y, Xu G, Zhao J . Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med. 2020; 26(6):842-844. DOI: 10.1038/s41591-020-0901-9. View

12.

Joris M, Pincemail J, Colson C, Joris J, Calmes D, Cavalier E . Exercise Limitation after Critical Versus Mild COVID-19 Infection: A Metabolic Perspective. J Clin Med. 2022; 11(15). PMC: 9332476. DOI: 10.3390/jcm11154322. View

13.

Clemente I, Sinatti G, Cirella A, Santini S, Balsano C . Alteration of Inflammatory Parameters and Psychological Post-Traumatic Syndrome in Long-COVID Patients. Int J Environ Res Public Health. 2022; 19(12). PMC: 9222533. DOI: 10.3390/ijerph19127103. View

14.

Ikizler T . COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do?. Am J Kidney Dis. 2020; 76(1):1-3. PMC: 7146661. DOI: 10.1053/j.ajkd.2020.03.008. View

15.

Silva G, Moura W, Santos K, Gomes D, Bandeira G, Guimaraes R . Long-Term Symptoms after Mild Coronavirus Disease in Healthy Healthcare Professionals: A 12-Month Prospective Cohort Study. Int J Environ Res Public Health. 2023; 20(2). PMC: 9865648. DOI: 10.3390/ijerph20021483. View

16.

Cai R, Zhang J, Zhu Y, Liu L, Liu Y, He Q . Mortality in chronic kidney disease patients with COVID-19: a systematic review and meta-analysis. Int Urol Nephrol. 2021; 53(8):1623-1629. PMC: 7778685. DOI: 10.1007/s11255-020-02740-3. View

17.

Correa H, Deus L, Araujo T, Reis A, Amorim C, Gadelha A . Phosphate and IL-10 concentration as predictors of long-covid in hemodialysis patients: A Brazilian study. Front Immunol. 2022; 13:1006076. PMC: 9562993. DOI: 10.3389/fimmu.2022.1006076. View

18.

Nasserie T, Hittle M, Goodman S . Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review. JAMA Netw Open. 2021; 4(5):e2111417. PMC: 8155823. DOI: 10.1001/jamanetworkopen.2021.11417. View

18.

Vetrugno G, Foti F, Grassi V, De-Giorgio F, Cambieri A, Ghisellini R . Malpractice Claims and Incident Reporting: Two Faces of the Same Coin?. Int J Environ Res Public Health. 2022; 19(23). PMC: 9739332. DOI: 10.3390/ijerph192316253. View

19.

Hilbrands L, Duivenvoorden R, Vart P, Franssen C, Hemmelder M, Jager K . COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration. Nephrol Dial Transplant. 2020; 35(11):1973-1983. PMC: 7665620. DOI: 10.1093/ndt/gfaa261. View